Sarang Desai, DO
Orthopaedic Surgery · Allen, TXNPI 1205002581
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $290,891 of the $393,508 with a category attached, or 73.9%. Depuy Synthes Products, Inc. accounts for 75.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2020 at $308,778 and has fallen 98.5% since, to $4,752 in 2025. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $4324.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$298K
- Fuse Medical, Inc.$46K
- Medical Device Business Services, Inc.$40K
- Paragon 28, Inc.$5K
- Curasan, Inc.$3K
- Arthrex$813
- plus $1K from 9 others
What the payments were for
- Consulting fees$92,54224%
- Speaking & faculty fees$290,89174%
- Travel & lodging$8,9552%
- Food & beverage$1,1190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 3 | $297,727 |
| Fuse Medical, Inc. | 6 | $46,026 |
| Medical Device Business Services, Inc. | 36 | $39,603 |
| Paragon 28, Inc. | 20 | $4,608 |
| Curasan, Inc. | 1 | $3,400 |
| Arthrex | 4 | $813 |
| Linvatec Corporation | 1 | $739 |
| Johnson & Johnson | 10 | $171 |
| Abanza Inc. | 1 | $138 |
| Anika Therapeutics, Inc. | 1 | $91 |
| Pylant Medical | 2 | $63 |
| Bioventus LLC | 2 | $52 |
| Stryker | 1 | $33 |
| Orthofix Medical, Inc. | 2 | $29 |
| Smith+Nephew | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FIBULINK Syndesmosis Repair System$290,891
- Portfolio$4,171
- Cerasorb Foam$3,400
- BioBrace 23mm$739
- Fibulink$561
- DYNACORD$266
- HEALIX KNOTLESS PEEK$266
- WasherCap Fixation System 10mm$138
- Kischner wire$138
How this compares
$393,508 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naproxen | 59 | $464 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $332 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Allen
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- James BrodskyDallas$2.5M
- Robert SchmidtFort Worth$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.